Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy

PURPOSE: The purpose of this study is to compare the outcomes of first-line systemic targeted therapy (TT) and immunotherapy (IT) in patients with metastatic renal cell carcinoma (mRCC). MATERIALS AND METHODS: This study was a retrospective review of the data of 262 patients treated with systemic IT...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung Han, Park, Weon Seo, Kim, Sun Ho, Joung, Jae Young, Seo, Ho Kyung, Lee, Kang Hyun, Chung, Jinsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946361/
https://www.ncbi.nlm.nih.gov/pubmed/26875203
http://dx.doi.org/10.4143/crt.2015.316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946361/
https://www.ncbi.nlm.nih.gov/pubmed/26875203
http://dx.doi.org/10.4143/crt.2015.316

Ejemplares similares